Meropenem Trihydrate: Research Evidence & Workflows
2026-09-01
Meropenem trihydrate is a broad-spectrum carbapenem antibiotic that inhibits bacterial cell wall synthesis through penicillin-binding protein binding. Product handling data and LC-MS/MS resistance evidence support its use in antibiotic resistance studies, bacterial infection treatment research, and controlled microbiology workflows.
(S)-Mephenytoin in Intestinal CYP2C19 Models
2026-08-31
Explore how (S)-Mephenytoin can function as a mechanistic CYP2C19 substrate probe in human pluripotent stem cell-derived intestinal models. This article explains how assay geometry, metabolite-resolved analysis, and organoid maturity determine the interpretation of pharmacokinetic data.
KR-12: From Membrane Mechanism to Translation
2026-08-31
KR-12 is more than a minimal LL-37 fragment: it is a mechanistic probe for understanding how residue position, membrane organization, and immune context shape antimicrobial performance. This thought-leadership guide connects the KR-12 human antimicrobial peptide to assay design, translational decision-making, anti-biofilm and immunomodulatory research, and the practical use of KR-12 (human) TFA.
Adult Stem Cell Methods: Protocols and Translation
2026-08-30
Adult Stem Cells Methods and Protocols, Second Edition presents a reproducibility-focused framework for isolating, characterizing, engineering, and applying adult stem cells in regenerative research. Its principal contribution is methodological: it connects cell biology protocols with tissue engineering, nanotechnology, transplantation, and drug-treatment considerations while emphasizing practical limits to clinical translation.
4-Ethylphenyl Sulfate: Applied Workflow Guide
2026-08-29
Use 4-ethylphenyl sulfate as both a renal dysfunction biomarker standard and a mechanistic probe for gut microbiota-brain interaction research. This guide translates uremic-toxin surface adsorption findings into practical LC-MS, PEO-interface, cell, and neurobehavioral workflows with troubleshooting built in.
2-APB as a Calcium-Signaling Assay Discriminator
2026-08-28
2-APB (2-aminoethoxydiphenyl borate) is more than an IP3R antagonist: it can help distinguish upstream PLCβ signaling from downstream calcium-entry phenotypes. This article develops an assay-centered framework linking 2-APB pharmacology to the sinapine–Gαq–PLCβ3 cardiovascular study.
Novel PDK4 Inhibitors for Metabolic Disease
2026-08-28
Lee and colleagues identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, highlighting compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related models. The study combines medicinal chemistry, biochemical testing, metabolic stability, pharmacokinetics, animal efficacy studies, and molecular docking to propose a new scaffold for PDK4-focused drug discovery.
Afatinib in Gastric Cancer Assembloid Assays
2026-08-27
Afatinib (BIBW 2992) can do more than suppress ErbB signaling: in patient-derived gastric cancer assembloids, it can help distinguish tumor-intrinsic dependence from stromal protection. This article presents an assay-centered framework for interpreting response, resistance, and translational relevance.
Cy5 Hydrazide for Carbonyl Labeling Workflows
2026-08-27
Cy5 hydrazide converts protein, glycoprotein, oligonucleotide, and selected nanoparticle carbonyls into far-red fluorescent readouts. This guide translates its chemistry into practical oxidative-stress, SDS-PAGE, and FAST nanoparticle workflows while addressing solubility, background, and labeling-specificity challenges.
Gepotidacin: Translational Leverage Against Resistance
2026-08-26
Gepotidacin, also known as GSK2140944, offers translational researchers a distinct way to interrogate bacterial DNA replication inhibition and resistance biology. This thought-leadership analysis connects its topoisomerase mechanism, assay strategy, pharmacokinetic evidence, and research-use implementation into a practical framework for antibacterial research.
RIPA Lysis Buffer (Strong) and Epigenetic Proof
2026-08-26
A translational framework for connecting prenatal glucocorticoid programming, MKP-1–MAPK biology, and reproducible protein-level evidence using strategically optimized lysis workflows.
Cefazedone–Etimicin PK: UFLC–MS/MS Study
2026-08-25
Cui and colleagues developed and validated an ultra-fast liquid chromatography–tandem mass spectrometry method for simultaneous measurement of cefazedone and etimicin in beagle dog plasma. The assay enabled a direct pharmacokinetic comparison of combined and single intravenous injections, with no obvious pharmacokinetic differences detected under the study conditions.
EZ Cap™ Firefly Luciferase mRNA Workflow
2026-08-25
Build sensitive reporter assays around Cap1-capped, polyadenylated luciferase mRNA, from RNase-controlled preparation through quantitative luminescence readout. The workflow also shows why delivery chemistry must be optimized independently for in vitro translation and in vivo imaging.
p-tau Ser356, NUAK Inhibition, and Alzheimer’s Disease
2026-08-24
The reference study links p-tau Ser356 to Braak stage, neurofibrillary tangles, and synaptic regions in Alzheimer’s disease brain tissue. Its ex vivo comparison further shows that NUAK inhibition produces distinct tau and neuronal responses in postnatal mouse versus adult human brain slice cultures, highlighting the importance of model context in therapeutic development.
GKT137831 for Nox1/Nox4 Redox Assays
2026-08-24
GKT137831 provides a practical way to separate Nox1/Nox4-driven reactive oxygen species signaling from downstream vascular, fibrotic, and ferroptosis-associated phenotypes. This workflow-focused guide covers dose selection, orthogonal readouts, controls, and troubleshooting for reproducible oxidative stress research.
570 records 7/38 page Previous Next First page 上5页 678910 下5页 Last page